bucladesine has been researched along with Acute Confusional Senile Dementia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Huang, J; Ji, L; Jiang, Q; Li, H; Liu, M; Mao, K; Wei, J; Wei, N; Wu, J; Xie, W; Yang, S; Yang, Z; Zhu, L | 1 |
| Aghsami, M; Pourahmad, J; Sepand, MR; Seyednejad, SA; Sharifzadeh, M; Yazdankhah, M | 1 |
| Abdollahi, M; Aliaghaei, A; Ghahremani, MH; Gholami, M; Guan, J; Khalaj, S; Khodagholi, F; Mohammadi, M; Sharifzadeh, M; Taghizadeh, GH; Yans, A | 1 |
| Arendt, T; Brückner, MK; Dietrich, K; Glöckner, P; Hilbrich, I; Rohn, S; Ueberham, E; Ueberham, U | 1 |
| Fukuchi, K; Furlong, CE; Leppig, KA; Martin, GM; Smith, AC; Sopher, BL | 1 |
| Gandy, S; Greengard, P; Sweeney, D; Xu, H | 1 |
| Fujita, T; Giambarella, U; Ikezu, T; Murayama, Y; Nishimoto, I | 1 |
| Avila, J; Moreno-Flores, MT; Sayas, CL; Wandosell, F | 1 |
| Albert, F; Cedazo-Mínguez, A; Cowburn, RF; Hamker, U; Hellweg, R; Jacobi, C; Meske, V; Ohm, TG; Veh, RW | 1 |
9 other study(ies) available for bucladesine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
cAMP/PKA signaling pathway contributes to neuronal apoptosis via regulating IDE expression in a mixed model of type 2 diabetes and Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Apoptosis; Blood Glucose; Bucladesine; Cells, Cultured; Cyclic AMP; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose Tolerance Test; Humans; Insulysin; Isoquinolines; Mice; Neurons; Protein Kinases; Signal Transduction; Sulfonamides | 2018 |
A cAMP analog attenuates beta-amyloid (1-42)-induced mitochondrial dysfunction and spatial learning and memory deficits.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Bucladesine; Cyclic AMP; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memory Disorders; Mitochondria; Mitochondrial Diseases; Neuroprotective Agents; Nootropic Agents; Oxidative Stress; Peptide Fragments; Rats, Wistar; Spatial Memory | 2018 |
Reduction of autophagy markers mediated protective effects of JNK inhibitor and bucladesine on memory deficit induced by Aβ in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anthracenes; Autophagy; Autophagy-Related Protein 12; Autophagy-Related Protein 7; Beclin-1; Bucladesine; Disease Models, Animal; Drug Therapy, Combination; JNK Mitogen-Activated Protein Kinases; Male; Maze Learning; Memory Disorders; Microtubule-Associated Proteins; Neuroprotective Agents; Protein Kinase Inhibitors; Rats, Wistar; Spatial Memory | 2016 |
Transcriptional control of cell cycle-dependent kinase 4 by Smad proteins--implications for Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Animals; Brain; Bucladesine; Cell Death; Cell Differentiation; Cell Line, Tumor; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase 4; Electrophoretic Mobility Shift Assay; Female; Gene Expression Regulation; Humans; Luciferases; Male; Mice; Neurites; Neuroblastoma; Neurons; Promoter Regions, Genetic; Protein Binding; Protein Biosynthesis; Protein Subunits; RNA, Small Interfering; Smad Proteins; Transfection | 2012 |
Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Brain; Bucladesine; Cell Line; Cell Survival; Flow Cytometry; Gene Expression; Humans; Neuroblastoma; Promoter Regions, Genetic; Recombinant Fusion Proteins; Restriction Mapping; Tetracycline; Transfection; Tumor Cells, Cultured | 1994 |
Metabolism of Alzheimer beta-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Bucladesine; Cell-Free System; Colforsin; Cyclic AMP-Dependent Protein Kinases; Cytosol; Enzyme Inhibitors; Ethers, Cyclic; Gene Expression Regulation; Golgi Apparatus; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Kinetics; Okadaic Acid; PC12 Cells; Protein Kinase C; Protein Processing, Post-Translational; Rats | 1996 |
Potential CRE suppression by familial Alzheimer's mutants of APP independent of adenylyl cyclase regulation.
Topics: Adenylyl Cyclases; Alzheimer Disease; Amyloid beta-Protein Precursor; Bucladesine; Cell Line; Cholera Toxin; Cyclic AMP; GTP-Binding Proteins; Humans; Mutation; Regulatory Sequences, Nucleic Acid; Transfection | 1997 |
The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation.
Topics: Alzheimer Disease; Bucladesine; Calcium-Calmodulin-Dependent Protein Kinases; Glycogen Synthase Kinase 3; Glycogen Synthase Kinases; Humans; Lysophospholipids; Neurites; Phosphorylation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; Reverse Transcriptase Polymerase Chain Reaction; tau Proteins; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1999 |
Regulation of apolipoprotein E secretion in rat primary hippocampal astrocyte cultures.
Topics: Alzheimer Disease; Animals; Animals, Newborn; Apolipoproteins E; Astrocytes; Bucladesine; Carbachol; Cell Survival; Cells, Cultured; Clonidine; Cyclic AMP; Drug Interactions; Hippocampus; Immunohistochemistry; Isoproterenol; Nerve Growth Factor; Norepinephrine; Protein Kinase C; Rats; Rats, Wistar; RNA, Messenger; Serotonin; Tetradecanoylphorbol Acetate; Tretinoin | 2001 |